↓ Skip to main content
What is this page? Embed badge

A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies

Overview of attention for article published in BMC Cancer, March 2013
Altmetric Badge

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
53 Mendeley
Summary Dimensions citations
So far, Dimensions has found 100 publications that cite this research output.

100

The most recent citing publications are shown below. View all 100 publications that cite this research output on Dimensions.

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.

This page is provided by Altmetric.